Double Malignancies: A Rare Entity

Subhashish Das*

Received: April 30, 2018;   Published: May 03, 2018

DOI: 10.32474/SCSOAJ.2018.01.000104

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF

Abstract

Patients which have diagnosed with a cancer, have a life time risk for developing another de novo malignancy depending on various inherited environmental and iatrogenic risk factors. Cancer victims could survive longer due to settling treatment modalities, and then would likely develop a new metachronous malignancy [1]. The incidence of multiple primary malignancies has not been rare at all. Screening procedures have especially been useful for the early detection of associated tumors, whereas careful monitoring of patients has treated for primary cancer, and then a good communication between patients and medical care team would certify not only an early detection for secondary tumors, but only finally & subsequently, an appropriate management [2].

Abbreviations: MPM: Multiple Primary Malignancies; SEER: Surveillance Epidemiology and End Results Programme; SPT: Second Primary Tumor; TT: Third Tumor; QT: Quadrant Tumor; SPM: Second Primary Malignancies; NAACCR: North American Association of Central Cancer Registries

Introduction| Conclusion| References|